Important News and Information 02/11/2026 U.S. FDA Approves Novocure’s Optune Pax® for the Treatment of Locally Advanced Pancreatic Cancer |
Connecticut Oncology Association (CtOA)
c/o Dawn Holcombe
33 Woodmar Circle
South Windsor, CT 06074
(860) 305-4510
Website design by Sister Webs Design Studio, where 5% of profits are donated to women's cancer funds